Alexandra M. M. Antunes obtained her degree in Chemistry in 1994 from Universidade de Lisboa and received her MSc in Industrial Organic Chemistry in 1998, from Universidade Nova de Lisboa (UNL). Before completing the PhD degree in Organic Chemistry by UNL, in 2003, she obtained a position in the lead national pharmaceutical company, BIAL. This experience provided valuable skills for her scientific area, which could not be achievable in academia. Namely, it has given her the know-how on deploying new techniques to the clinical realm. In 2006 she became Assistant Researcher at REQUIMTE (UNL) and from 2007 to 2008 she was simultaneously an Invited Assistant Professor at UNL. In 2008 she obtained a position as Assistant Researcher at the CQE, where she established her own research line aimed at using protein adductomics tools not only for disclosing the underlying mechanisms of chemically-induced adverse effects (including non-communicable diseases) but also the development of adequate compound-specific biomarkers of toxicity/exposure. More recently, she is also leading several projects aimed at developing diagnosis tools In 2017, she co-founded a startup company, Clarify Analytical, dedicated at the development of diagnostic methods based on the mass spectrometry technique, which was awarded by an EU-funded project from the H2020 SMEInvestment program. Alexandra Antunes authored more than 70 peer reviewed publications and completed the supervision of 5 PhD students and 25 MSc students. Additionally, she works as consultant with the scientific police, for the identification of toxic compounds in forensic scenarios, and with a national pharmaceutical company that provides funding for her research. The international recognition of the high standard of her research work was fully attested by CEFIC-LRI AWARD, one of Europe’s largest research grants for early career toxicologists, which she received in 2014.